Skip to main content
. 2016 Feb 23;7(14):18135–18145. doi: 10.18632/oncotarget.7636

Figure 4. Actuarial LC and OS from time of diagnosis and from SRT for patients with oligometastases or oligorecurrence to MLNs.

Figure 4

A. Actuarial LC for all patients; B. OS from diagnosis and from SRT for all patients; C. OS from diagnosis and from SRT for patients with NSCLC; D. OS for NSCLC patients by: interval time between diagnosis of the primary tumor and SRT (upper left); MLN PTV (upper right); presence or absence of CT (lower right); and presence or absence of symptoms (lower left). LC: local control; OS: overall survival; SRT: stereotactic radiation therapy; MLN: mediastinal lymph node; NSCLC: non-small cell lung cancer; PTV: planning target volume; CT: chemotherapy.